Greenbaum CJ - Search Results

1

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.

Wherrett DK, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Herold KC, Marks JB, Monzavi R, Moran A, Orban T, Palmer JP, Raskin P, Rodriguez H, Schatz D, Wilson DM, Krischer JP, Skyler JS; Type 1 Diabetes TrialNet GAD Study Group. Wherrett DK, et al. Among authors: greenbaum cj. Lancet. 2011 Jul 23;378(9788):319-27. doi: 10.1016/S0140-6736(11)60895-7. Epub 2011 Jun 27. Lancet. 2011. PMID: 21714999 Free PMC article. Clinical Trial.

2

Fifth International Serum Exchange Workshop for Insulin Autoantibody (IAA) Standardization. The Immunology and Diabetes Workshops and participating laboratories.

Greenbaum CJ, Wilkin TJ, Palmer JP. Greenbaum CJ, et al. Diabetologia. 1992 Aug;35(8):798-800. doi: 10.1007/BF00429105. Diabetologia. 1992. PMID: 1511809 No abstract available.

3

Insulin antibodies and insulin autoantibodies.

Greenbaum CJ, Palmer JP. Greenbaum CJ, et al. Diabet Med. 1991 Feb-Mar;8(2):97-105. doi: 10.1111/j.1464-5491.1991.tb01553.x. Diabet Med. 1991. PMID: 1827408 Review. No abstract available.

4

Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM.

Greenbaum CJ, Kahn SE, Palmer JP. Greenbaum CJ, et al. Diabetes. 1996 Nov;45(11):1631-4. doi: 10.2337/diab.45.11.1631. Diabetes. 1996. PMID: 8866571 Clinical Trial.

5

Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.

Greenbaum CJ, Sears KL, Kahn SE, Palmer JP. Greenbaum CJ, et al. Diabetes. 1999 Jan;48(1):170-5. doi: 10.2337/diabetes.48.1.170. Diabetes. 1999. PMID: 9892239

6

Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: identification by the Diabetes Prevention Trial-type 1.

Greenbaum CJ, Schatz DA, Cuthbertson D, Zeidler A, Eisenbarth GS, Krischer JP. Greenbaum CJ, et al. J Clin Endocrinol Metab. 2000 Mar;85(3):1255-60. doi: 10.1210/jcem.85.3.6459. J Clin Endocrinol Metab. 2000. PMID: 10720072 Clinical Trial.

7

Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.

Greenbaum CJ, Cuthbertson D, Krischer JP; Disease Prevention Trial of Type I Diabetes Study Group. Greenbaum CJ, et al. Diabetes. 2001 Feb;50(2):470-6. doi: 10.2337/diabetes.50.2.470. Diabetes. 2001. PMID: 11272162

8

Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.

Juneja R, Hirsch IB, Naik RG, Brooks-Worrell BM, Greenbaum CJ, Palmer JP. Juneja R, et al. Among authors: greenbaum cj. Metabolism. 2001 Sep;50(9):1008-13. doi: 10.1053/meta.2001.25654. Metabolism. 2001. PMID: 11555830 Clinical Trial.

9

Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J. Schatz D, et al. Pediatr Diabetes. 2004 Jun;5(2):72-9. doi: 10.1111/j.1399-543X.2004.00047.x. Pediatr Diabetes. 2004. PMID: 15189492 Clinical Trial.

10

Male sex increases the risk of autoimmunity but not type 1 diabetes.

Krischer JP, Cuthbertson DD, Greenbaum C; Diabetes Prevention Trial-Type 1 Study Group. Krischer JP, et al. Diabetes Care. 2004 Aug;27(8):1985-90. doi: 10.2337/diacare.27.8.1985. Diabetes Care. 2004. PMID: 15277428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page